(2,4-dichloro-phenyl)-isobutyl ether | 6851-42-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2,4-dichloro-phenyl)-isobutyl ether
• 英文别名: (2,4-Dichlor-phenyl)-isobutyl-aether；2,4-Dichlorophenol, 2-methylpropyl ether；2,4-dichloro-1-(2-methylpropoxy)benzene
• CAS: 6851-42-9
• 化学式: C₁₀H₁₂Cl₂O
• 分子量: 219.111
• InChiKey: HWDGBTSNJVCVQO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  碘代异丁烷 、 2,4-二氯酚 在 环己酮 、 potassium carbonate 作用下， 生成 (2,4-dichloro-phenyl)-isobutyl ether
  参考文献：
  名称：

  次卤酸芳族卤化反应的动力学和机理。第二部分 次溴酸在芳香族醚的溴化中取代基的指导作用

  摘要：

  DOI：

  10.1039/jr9550002921

文献信息

• Substituted Fused Pyrimidinones and Dihydropyrimidinones
  申请人：FRACKENPOHL Jens

  公开号：US20120157306A1

  公开（公告）日：2012-06-21

  The use of substituted fused pyrimidinones and dihydropyrimidinones of the formula (I) or salts thereof where the radicals of the formula (I) are each as defined in the description, for enhancing stress tolerance in plants to abiotic stress, and for invigorating plant growth and/or for increasing plant yield.

  使用公式（I）中定义的基团的取代融合嘧啶酮和二氢嘧啶酮或其盐，用于增强植物对非生物胁迫的耐受性，激发植物生长和/或增加植物产量。
• SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES
  申请人：BAYER INTELLECTUAL PROPERTY GMBH

  公开号：US20150173359A1

  公开（公告）日：2015-06-25

  The use of substituted fused pyrimidinones and dihydropyrimidinones of the formula (I) or salts thereof where the radicals of the formula (I) are each as defined in the description, for enhancing stress tolerance in plants to abiotic stress, and for invigorating plant growth and/or for increasing plant yield.

  使用式(I)中的替代融合嘧啶酮和二氢嘧啶酮或其盐，其中式(I)的基团如描述中所定义，用于增强植物对非生物胁迫的耐受性，促进植物生长和/或增加植物产量。
• Methods for treating cryptosporidiosis using triazolopyridazines
  申请人：University of Vermont and State Agricultural College

  公开号：US10363254B2

  公开（公告）日：2019-07-30

  Methods for treating or prophylaxis of a Cryptosporidium infection using compositions comprising a structure disclosed herein. Also provided are pharmaceutical compositions and kits for alleviating the symptoms of, for treating, or for preventing the occurrence of Cryptosporidium infection. The kits comprise one or more compounds having a structure disclosed herein, such as in an oral composition, and instructions for use, storage, and the like.

  使用包含本文公开的结构的组合物治疗或预防隐孢子虫感染的方法。还提供了用于缓解隐孢子虫感染症状、治疗或预防隐孢子虫感染发生的药物组合物和试剂盒。这些试剂盒包括一种或多种具有本文所公开结构的化合物，如口服组合物，以及使用、储存等说明。
• 5 HT RECEPTOR MEDIATED NEUROGENESIS
  申请人：Barlow Carrolee

  公开号：US20100009983A1

  公开（公告）日：2010-01-14

  The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, in combination with one or more other neurogenic agents, or anti-astrogenic agent, to stimulate or activate the formation of new nerve cells.
• METHODS FOR TREATING CRYPTOSPORIDIOSIS USING TRIAZOLOPYRIDAZINES
  申请人：University of Vermont and State Agricultural College

  公开号：US20180064711A1

  公开（公告）日：2018-03-08

  Methods for treating or prophylaxis of a Cryptosporidium infection using compositions comprising a structure disclosed herein. Also provided are pharmaceutical compositions and kits for alleviating the symptoms of, for treating, or for preventing the occurrence of Cryptosporidium infection. The kits comprise one or more compounds having a structure disclosed herein, such as in an oral composition, and instructions for use, storage, and the like.